Norgestimate Production Cost Reports

The report provides a detailed analysis essential for establishing a Norgestimate production plant. It encompasses all critical aspects necessary for Norgestimate production, including the cost of Norgestimate production, Norgestimate plant cost, Norgestimate production costs, and the overall Norgestimate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Norgestimate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Norgestimate is a third-generation progestin that is utilised in combination with oral contraceptives like ethinyl Estradiol. It prevents pregnancy through ovulation suppression, cervical mucus thickening to block sperm entry, and endometrial thinning to inhibit implantation. It is available in monophasic, triphasic, and extended-cycle formulations for improved cycle control and reduced breakthrough bleeding.

It is also used for treating moderate acne in females aged 15 or older seeking contraception by decreasing sebum production and inflammation via antiandrogenic effects. It is utilised to manage heavy menstrual bleeding (menorrhagia), dysmenorrhea, and polycystic ovary syndrome symptoms through cycle regulation.  Its common side effects include nausea, headache, breast tenderness, mood changes, breakthrough bleeding, weight gain, and spotting.

The market for Norgestimate is driven by rising global demand for reliable combination oral contraceptives. The expanding family planning programs, rise in reproductive health awareness, and need for convenient hormonal options with low androgenic profiles for cycle control and acne management contribute to its market growth.

The strong healthcare infrastructure, regulatory approvals for generics, and preferences for formulations offering reduced breakthrough bleeding and VTE risks compared to other options fuel its market. The industrial Norgestimate procurement is influenced by complex steroidal API synthesis requiring specialised facilities. Also, regulatory demands for impurity profiling, supply chain dependencies on key manufacturers, and price instability from generic competition affects it sourcing.

Raw Material for Norgestimate Production

According to the Norgestimate production plant project report, the key raw materials used in the production of Norgestimate include D-norgestrel, Pyridine, and Hydroxylamine Hydrochloride.

Production Process of Norgestimate

The extensive Norgestimate production cost report consists of the following major industrial production process:

1. By Oximation: The production process involves oximation of D-norgestrel. The process starts with heating D-norgestrel in pyridine and hydroxylamine hydrochloride together. The mixture is cooled and poured into ice-water to precipitate the solid product. This is filtered, air-dried, and recrystallised from methylene chloride-ethanol to get Norgestimate as the final product.

Norgestimate appears as a white to off-white crystalline powder with the molecular formula C23H31NO3 and molecular weight of 369.5 g/mol. It features a steroid structure with a 3-ketoxime, 17α-ethynyl group, and acetate ester that goes through rapid CYP3A4-mediated deacetylation to active metabolites like 17-desacetylnorgestimate and norgestrel. It displays low water solubility below 0.1 g/L. It has high lipophilicity with logP 4.1 and has a melting point of 214-218 degree Celsius. It has a topological polar surface area of 58.9 Ų that makes it ideal for oral contraceptive formulations. It remains stable under standard conditions but is poorly soluble in water and better in organic solvents.